Crohn's disease management: translating STRIDE-II for UK clinical practice
K Kemp, MA Samaan, AM Verma… - Therapeutic Advances …, 2024 - journals.sagepub.com
Crohn's disease (CD) is a chronic inflammatory bowel disease (IBD) characterised by
endoscopic inflammation, progressive bowel damage and gastrointestinal lesions. Although …
endoscopic inflammation, progressive bowel damage and gastrointestinal lesions. Although …
[HTML][HTML] Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
S Salvador-Martín, G Rubbini, P Vellosillo… - Biomedicine & …, 2024 - Elsevier
Background/aims Changes in gene expression profiles among individuals with inflammatory
bowel diseases (IBDs) could potentially influence the responsiveness to anti-TNF treatment …
bowel diseases (IBDs) could potentially influence the responsiveness to anti-TNF treatment …
Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
R Chen, L Li, Y Tie, M Chen… - Precision Clinical …, 2023 - academic.oup.com
Objectives To investigate the characteristics and prognostic value of fecal lactoferrin
trajectories in ulcerative colitis (UC). Methods This study used data from the UNIFI trial …
trajectories in ulcerative colitis (UC). Methods This study used data from the UNIFI trial …
[HTML][HTML] Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases
S Bencardino, F D'Amico, A Zilli… - Journal of …, 2024 - xiahepublishing.com
The incidence and prevalence of inflammatory bowel diseases (IBD), including ulcerative
colitis and Crohn's disease, are rapidly increasing. Currently, colonoscopy is the gold …
colitis and Crohn's disease, are rapidly increasing. Currently, colonoscopy is the gold …
Developing and Externally Validating a Simple Index Based on the Nonlinear Relationship of Fecal Calprotectin and Long-Term Outcomes in Ulcerative Colitis
J Zheng, D Zheng, Z Fan, L Li, R Chen… - Journal of Inflammation …, 2024 - Taylor & Francis
Background The possible nonlinear association with therapeutic outcomes in ulcerative
colitis may contribute to the inconclusive cutoff values of fecal calprotectin (FC). We aimed to …
colitis may contribute to the inconclusive cutoff values of fecal calprotectin (FC). We aimed to …
[HTML][HTML] An Atypical Case of Yersinia enterocolitica Infection in a Patient Suspected With Ulcerative Colitis Flare-Up
P Doshi, G Sivaram, C Sievers - Cureus, 2024 - ncbi.nlm.nih.gov
Ulcerative colitis (UC), one of the two major inflammatory bowel diseases (IBD), is a chronic
immune-mediated inflammatory disorder with varying degrees of colonic mucosal …
immune-mediated inflammatory disorder with varying degrees of colonic mucosal …
[HTML][HTML] Laboratory Diagnosis of Ulcerative Colitis and the Possibility of Personalized Assessment in Real Conditions
GH Babayeva, MT Ramazanov, NO Isgandarov… - 2024 - intechopen.com
Laboratory diagnostics of ulcerative colitis today are based on a limited number of used
laboratory markers; in most cases, these are C-reactive protein and fecal calprotectin …
laboratory markers; in most cases, these are C-reactive protein and fecal calprotectin …